Trademark: 29E.2A3
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for 29E.2A3
We do not have any records of a proof of use for 29E.2A3 at this moment.
Possible trademark infringements of 29E.2A3
Basic Information about 29E.2A3
- Serial Number
- 97914757
- Filing Date
- 01 May 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of 29E.2A3 on the blockchain with WikiTrademarks.io.
- First use of 29E.2A3 anywhere
- 29E.2A3 was first used on 31 Dec 1999 for the primary classification of goods and services, international, 001 (Chemicals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 001
- US Codes
- 001; 005; 006; 010; 026; 046
- First use of 29E.2A3 anywhere
- 29E.2A3 was first used on 31 Dec 1999 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns 29E.2A3?
1. Dana-Farber Cancer Institute, Inc. Boston MA
Correspondent
- Douglas R. Wolf WOLF GREENFIELD & SACKS, P.C.
- 600 ATLANTIC AVENUE
- BOSTON, MA 02210
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io